Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

Kyle J Gaulton, Teresa Ferreira, Yeji Lee, Anne Raimondo, Reedik Mägi, Michael E Reschen, Anubha Mahajan, Adam Locke, N William Rayner, Neil Robertson, Robert A Scott, Inga Prokopenko, Laura J Scott, Todd Green, Thomas Sparso, Dorothee Thuillier, Loic Yengo, Harald Grallert, Simone Wahl, Mattias FrånbergRona J Strawbridge, Hans Kestler, Himanshu Chheda, Lewin Eisele, Stefan Gustafsson, Valgerdur Steinthorsdottir, Gudmar Thorleifsson, Lu Qi, Lennart C Karssen, Elisabeth M van Leeuwen, Sara M Willems, Man Li, Han Chen, Christian Fuchsberger, Phoenix Kwan, Clement Ma, Michael Linderman, Yingchang Lu, Soren K Thomsen, Jana K Rundle, Niels Grarup, Christian T Have, Anna Jonsson, Marit Eika Jørgensen, Torben Jørgensen, Allan Linneberg, Petter Storm, Inger Njølstad, Torben Hansen, Oluf Pedersen, Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium

227 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci'. Together they form a unique fingerprint.

Medicine & Life Sciences